Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Direct vs. Conventional SLT in Open-Angle Glaucoma: A RCT

NCT: NCT06925477 · ENROLLING_BY_INVITATION

NCT IDNCT06925477
StatusENROLLING_BY_INVITATION
Start Date2025-08-07
Completion2027-11-30
SponsorMedical University of South Carolina (OTHER)
First posted
Last updated

Brief Summary

This study compares two laser treatments for open-angle glaucoma: Selective Laser Trabeculoplasty (SLT) and Direct Selective Laser Trabeculoplasty (DSLT). SLT is a widely used procedure that requires a manual technique with a goniolens, while DSLT is a new, automated, non-contact method using the Eagle system. The study will evaluate whether DSLT is as effective as SLT in reducing intraocular pressure (IOP). Participants will be randomly assigned to receive either treatment and will be monitored over 12 months to assess changes in IOP, medication use, and safety outcomes. The goal is to determine if the simpler DSLT procedure can provide similar results to SLT, potentially improving patient comfort and access to glaucoma care.

Frequently Asked Questions

What is Direct vs. Conventional SLT in Open-Angle Glaucoma: A RCT?

Direct vs. Conventional SLT in Open-Angle Glaucoma: A RCT is a clinical trial registered under NCT06925477. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT06925477?

The current status of NCT06925477 (Direct vs. Conventional SLT in Open-Angle Glaucoma: A RCT) is: ENROLLING_BY_INVITATION.

When did Direct vs. Conventional SLT in Open-Angle Glaucoma: A RCT start?

Direct vs. Conventional SLT in Open-Angle Glaucoma: A RCT started on 2025-08-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.